Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Extragonadal Germ Cell Tumors

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Extragonadal Germ Cell Tumors

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      clinically-proposed
      derivation note
      Derived from NCI topic(s): Extragonadal Germ Cell Tumors. Strongest NCIt resolution: candidate. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
      source wording
      Source null
      1 more-specific settings
      recurrent Extragonadal Germ Cell Tumors →

      Study evidence for this setting

      9 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00002558 · Registry condition search · Scope: narrower

      Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

      1 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00002931 · Registry condition search · Scope: narrower

      Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00104676 · Registry condition search · Scope: narrower

      Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

      2 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00423852 · Registry condition search · Scope: narrower

      Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

      2 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00453310 · Registry condition search · Scope: narrower

      Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

      1 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00470366 · Registry condition search · Scope: narrower

      Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00957905 · Registry condition search · Scope: narrower

      Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

      4 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01037790 · Registry condition search · Scope: narrower

      Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

      1 outcome links · 5 safety-group records · 0 quality-of-life measures

      →

      NCT01808534 · Registry condition search · Scope: narrower

      Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-extragonadal-germ-cell-tumors
        binding id
        ncit-C3918
        source collection
        ncit-concept
        source key
        C3918
        source excerpt
        Source null
        match status
        candidate
        match note
        Resolution status: candidate.
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice